Gali Heimer

3.3k total citations
56 papers, 1.2k citations indexed

About

Gali Heimer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Gali Heimer has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 11 papers in Genetics. Recurrent topics in Gali Heimer's work include Neuroscience and Neuropharmacology Research (8 papers), Neurological disorders and treatments (8 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Gali Heimer is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurological disorders and treatments (8 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Gali Heimer collaborates with scholars based in Israel, United States and United Kingdom. Gali Heimer's co-authors include Hagai Bergman, C. E. D. Taylor, Izhar Bar‐Gad, Michal Rivlin‐Etzion, Joshua A. Goldberg, Ya’acov Ritov, Odeya Marmor, Aeyal Raz, Asaph Nini and Andreea Nissenkorn and has published in prestigious journals such as The Lancet, Journal of Neuroscience and Neurology.

In The Last Decade

Gali Heimer

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gali Heimer Israel 18 596 541 321 205 117 56 1.2k
Sigurd D. Süßmuth Germany 26 520 0.9× 939 1.7× 511 1.6× 108 0.5× 34 0.3× 49 1.7k
Christopher R. Bye Australia 23 508 0.9× 393 0.7× 682 2.1× 95 0.5× 96 0.8× 31 1.8k
Alexandra Benchoua France 19 470 0.8× 165 0.3× 1.1k 3.5× 88 0.4× 169 1.4× 34 1.6k
G. Krinke Switzerland 21 254 0.4× 186 0.3× 214 0.7× 38 0.2× 58 0.5× 74 1.2k
Tomohide Goto Japan 18 328 0.6× 101 0.2× 602 1.9× 57 0.3× 165 1.4× 67 1.3k
Francesca Macchi Italy 18 192 0.3× 217 0.4× 252 0.8× 75 0.4× 91 0.8× 29 782
Liliane Tenenbaum Belgium 23 659 1.1× 167 0.3× 1000 3.1× 72 0.4× 632 5.4× 56 2.0k
Hiroshi Kaneko Japan 19 372 0.6× 62 0.1× 361 1.1× 307 1.5× 75 0.6× 56 1.4k
Tao Feng China 19 135 0.2× 529 1.0× 409 1.3× 110 0.5× 312 2.7× 70 1.3k
Michael Gonzalez United States 26 727 1.2× 182 0.3× 1.0k 3.2× 54 0.3× 236 2.0× 47 1.9k

Countries citing papers authored by Gali Heimer

Since Specialization
Citations

This map shows the geographic impact of Gali Heimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gali Heimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gali Heimer more than expected).

Fields of papers citing papers by Gali Heimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gali Heimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gali Heimer. The network helps show where Gali Heimer may publish in the future.

Co-authorship network of co-authors of Gali Heimer

This figure shows the co-authorship network connecting the top 25 collaborators of Gali Heimer. A scholar is included among the top collaborators of Gali Heimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gali Heimer. Gali Heimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heimer, Gali, et al.. (2025). Unraveling MECP2 structural variants in previously elusive Rett syndrome cases through IGV interpretation. npj Genomic Medicine. 10(1). 23–23. 1 indexed citations
2.
Mor, Nofar, S. Raviv, Yoach Rais, et al.. (2024). Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder. Molecular Therapy — Nucleic Acids. 36(1). 102432–102432. 2 indexed citations
3.
Keary, Christopher J., Lynne M. Bird, Marie‐Claire Y. de Wit, et al.. (2023). Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study. European Journal of Paediatric Neurology. 47. 6–12. 6 indexed citations
4.
Dutta, Debdeep, Oguz Kanca, Seul Kee Byeon, et al.. (2023). A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels. Nature Metabolism. 5(9). 1595–1614. 7 indexed citations
5.
Gruber, Noah, et al.. (2023). Short Stature and Distinct Growth Characteristics in Angelman Syndrome. Hormone Research in Paediatrics. 97(4). 334–342. 1 indexed citations
6.
Tzadok, Michal, et al.. (2022). The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy. Pediatric Neurology. 136. 15–19. 4 indexed citations
7.
Fattal‐Valevski, Aviva, Liat Ben‐Sira, Tally Lerman‐Sagie, et al.. (2021). Delineation of the phenotype of MED17-related disease in Caucasus-Jewish families. European Journal of Paediatric Neurology. 32. 40–45. 4 indexed citations
9.
Nissenkorn, Andreea, Tomer Erlich, Dorit E. Zilberman, et al.. (2018). Secondary enuresis and urological manifestations in children with ataxia telangiectasia. European Journal of Paediatric Neurology. 22(6). 1118–1123. 1 indexed citations
10.
Heimer, Gali, Eran Eyal, Xiaolin Zhu, et al.. (2017). Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin. European Journal of Paediatric Neurology. 22(1). 93–101. 37 indexed citations
11.
Ardon, Orly, Melinda Procter, Rong Mao, et al.. (2016). Creatine transporter deficiency: Novel mutations and functional studies. Molecular Genetics and Metabolism Reports. 8. 20–23. 15 indexed citations
12.
Heimer, Gali, Danit Oz-Levi, Eran Eyal, et al.. (2015). TECPR2 mutations cause a new subtype of familial dysautonomia like hereditary sensory autonomic neuropathy with intellectual disability. European Journal of Paediatric Neurology. 20(1). 69–79. 27 indexed citations
13.
Slae, Mordechai, Merav Heshin‐Bekenstein, Ari M. Simckes, et al.. (2013). Female polysomy-X and systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 43(4). 508–512. 15 indexed citations
14.
Elias, Shlomo, Mati Joshua, Joshua A. Goldberg, et al.. (2007). Statistical Properties of Pauses of the High-Frequency Discharge Neurons in the External Segment of the Globus Pallidus. Journal of Neuroscience. 27(10). 2525–2538. 76 indexed citations
15.
Heimer, Gali, Michal Rivlin‐Etzion, Izhar Bar‐Gad, et al.. (2006). Dopamine Replacement Therapy Does Not Restore the Full Spectrum of Normal Pallidal Activity in the 1-Methyl-4-Phenyl-1,2,3,6-Tetra-Hydropyridine Primate Model of Parkinsonism. Journal of Neuroscience. 26(31). 8101–8114. 84 indexed citations
16.
Heimer, Gali, Michal Rivlin‐Etzion, Zvi Israel, & Hagai Bergman. (2006). Synchronizing activity of basal ganglia and pathophysiology of Parkinson’s disease. PubMed. 17–20. 23 indexed citations
17.
Rivlin‐Etzion, Michal, Ya’acov Ritov, Gali Heimer, Hagai Bergman, & Izhar Bar‐Gad. (2006). Local Shuffling of Spike Trains Boosts the Accuracy of Spike Train Spectral Analysis. Journal of Neurophysiology. 95(5). 3245–3256. 72 indexed citations
18.
Rivlin‐Etzion, Michal, Odeya Marmor, Gali Heimer, et al.. (2006). Basal ganglia oscillations and pathophysiology of movement disorders. Current Opinion in Neurobiology. 16(6). 629–637. 147 indexed citations
19.
Heimer, Gali, et al.. (1968). An evaluation of the Technicon AutoAnalyzer for automating complement-fixation tests. Journal of Clinical Pathology. 21(4). 521–526. 7 indexed citations
20.
Taylor, C. E. D. & Gali Heimer. (1964). Rapid Diagnosis of Sonne Dysentery by Means of Immunofluorescence. BMJ. 2(5402). 165–166. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026